Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07405801

1 development in the corpus

NCT07405801

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 11, 2026 · PHASE 2 TRIAL

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

ClinicalTrials.gov

This is an actively recruiting Phase 2 trial with no results posted; the registry record describes design and planned endpoints only, not outcomes.

PreliminaryRibociclib NCT07405801 Inavolisib

Reported

Planned enrollment80

PhasePhase 2

Primary endpointPercentage of Participants With Confirmed O…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support